Nadiminti KVG - Search Results

1

Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation.

You X, Liu F, Binder M, Vedder A, Lasho T, Wen Z, Gao X, Flietner E, Rajagopalan A, Zhou Y, Finke C, Mangaonkar A, Liao R, Kong G, Ranheim EA, Droin N, Hunter AM, Nikolaev S, Balasis M, Abdel-Wahab O, Levine RL, Will B, Nadiminti KVG, Yang D, Geissler K, Solary E, Xu W, Padron E, Patnaik MM, Zhang J. You X, et al. Among authors: nadiminti kvg. Blood. 2022 Feb 17;139(7):1066-1079. doi: 10.1182/blood.2021012519. Blood. 2022. PMID: 34699595 Free PMC article.

2

Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma.

Nadiminti K, Sidiqi MH, Meleveedu K, Alkhateeb HB, Hogan WJ, Litzow M, Patnaik M, Kumar S, Gertz M, Chen D, Shah MV. Nadiminti K, et al. Blood Cancer J. 2021 Mar 19;11(3):63. doi: 10.1038/s41408-021-00454-y. Blood Cancer J. 2021. PMID: 33741897 Free PMC article. No abstract available.

3

PD-1/PD-L1 expression in extramedullary lesions of acute myeloid leukemia.

Meleveedu KS, Chen D, Nadiminti K, Sidiqi H, Khan S, Alkhateeb H, Shah MV, Patnaik M, Hogan WJ, Begna K, Litzow M. Meleveedu KS, et al. Leuk Lymphoma. 2021 Mar;62(3):764-767. doi: 10.1080/10428194.2019.1675880. Epub 2019 Oct 12. Leuk Lymphoma. 2021. PMID: 31608729 No abstract available.

4

A novel Iowa-Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction.

Nadiminti K, Langer K, Shabbir E, Hefazi M, Dozeman L, Jethava Y, Loeffler B, AlKhateeb HB, Litzow M, Patnaik M, Shah M, Hogan W, Farooq U, Silverman M, Mott SL. Nadiminti K, et al. Blood Cancer J. 2021 Nov 20;11(11):183. doi: 10.1038/s41408-021-00573-6. Blood Cancer J. 2021. PMID: 34802042 Free PMC article. Clinical Trial.

5

A Case of Isolated Myeloid Sarcoma Associated With Germline EGFR T790M Variant: The Importance of Recognizing Potential Germline Variants on Somatic Tumor Sequencing Panels.

Walker M, Folstad M, Smith-Simmer K, Reinig E, Nadiminti K, Lovrien L, Churpek JE, Banaszak LG. Walker M, et al. J Hematol. 2022 Apr;11(2):71-76. doi: 10.14740/jh983. Epub 2022 Apr 12. J Hematol. 2022. PMID: 35573754 Free PMC article.

6

VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma.

Nadiminti K, Singh Abbi KK, Mott SL, Dozeman L, Tricot A, Schultz A, Behrends S, Zhan F, Tricot G. Nadiminti K, et al. Onco Targets Ther. 2017 Jan 6;10:217-226. doi: 10.2147/OTT.S112423. eCollection 2017. Onco Targets Ther. 2017. PMID: 28123303 Free PMC article.

7

t(15; 17) associated with primary myelofibrosis: a case report of an unusual clinical presentation and diagnostic dilemma.

Nadiminti K, Silverman M, Bhagavathi S, Vikas P. Nadiminti K, et al. Onco Targets Ther. 2019 Jul 11;12:5449-5455. doi: 10.2147/OTT.S208290. eCollection 2019. Onco Targets Ther. 2019. PMID: 31371984 Free PMC article.

8

Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma.

Abbi KK, Silverman M, Farooq U, Tricot A, Dozeman L, Nadiminti K, Krasowski MD, Tricot GJ. Abbi KK, et al. Br J Haematol. 2016 Aug;174(4):536-40. doi: 10.1111/bjh.14081. Epub 2016 May 12. Br J Haematol. 2016. PMID: 27172326 Free article.

9

Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma.

Gao M, Bai H, Jethava Y, Wu Y, Zhu Y, Yang Y, Xia J, Cao H, Franqui-Machin R, Nadiminti K, Thomas GS, Salama ME, Altevogt P, Bishop G, Tomasson M, Janz S, Shi J, Chen L, Frech I, Tricot G, Zhan F. Gao M, et al. J Natl Cancer Inst. 2020 May 1;112(5):507-515. doi: 10.1093/jnci/djz159. J Natl Cancer Inst. 2020. PMID: 31406992 Free PMC article.

10

Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma.

Zhan X, Yu W, Franqui-Machin R, Bates ML, Nadiminti K, Cao H, Amendt BA, Jethava Y, Frech I, Zhan F, Tricot G. Zhan X, et al. Oncotarget. 2017 Nov 27;8(67):111213-111224. doi: 10.18632/oncotarget.22740. eCollection 2017 Dec 19. Oncotarget. 2017. PMID: 29340048 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters